Holen Sie sich die Stockscreener-App
136.02
1.51%
2.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$134.00
Offen:
$133.45
24-Stunden-Volumen:
9.10M
Relative Volume:
4.60
Marktkapitalisierung:
$21.57B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$-1.58B
KGV:
-5.1116
EPS:
-26.61
Netto-Cashflow:
$546.00M
1W Leistung:
-5.46%
1M Leistung:
+3.30%
6M Leistung:
+25.65%
1J Leistung:
-0.64%
1-Tages-Spanne:
$133.08
$137.69
1-Wochen-Bereich:
$130.31
$148.51
52-Wochen-Spanne:
$100.08
$156.66
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
136.02 | 21.57B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated (ILMN) - Seeking Alpha
Illumina, Inc. (ILMN) Sees Modest Gains Amid Regulatory Approvals and Market Speculation - Insider Monkey
Studying epigenetics to avoid unwanted effects of blood transfusions - Illumina
Franklin Resources Inc. Sells 70,305 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Video: Illumina showcases innovations at the 7th China International Import Expo - Illumina
Illumina Revolutionizes Healthcare: Inside Look at Leaders Shaping the Future of Genomics Technology - StockTitan
Metagenomics Market to See Booming Growth 2024-2031 | Bio-Rad - openPR
Explore our partnerships - Illumina
Ovation.io and Illumina Collaborate to Advance Genomic Data Research - BioSpace
Ovation and Illumina partner to advance precision medicine - Investing.com
Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Stock Holdings Boosted by B. Riley Wealth Advisors Inc. - MarketBeat
DNA Test Kits Market Growth in Future Scope 2024-2031 | Devyser, - openPR
Y Intercept Hong Kong Ltd Cuts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Clinical Oncology Next Generation Sequencing Market Top - openPR
Genomic Cancer Testing Market Top PlayersIllumina, Inc., - openPR
Nasdaq 100 Shakeup: 3 Stocks That Can Gain - Investing.com
What's Going On With Illumina Stock On Monday?Illumina (NASDAQ:ILMN) - Benzinga
Sustainable Sequencing in the New MiSeq i100 Series - Yahoo Finance
Wilmington Savings Fund Society FSB Acquires New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Toronto Dominion Bank Grows Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Sees Large Increase in Short Interest - MarketBeat
Illumina's SWOT analysis: stock faces pricing headwinds amid market leadership - Investing.com Australia
Geode Capital Management LLC Acquires 48,018 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index - Benzinga
MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed - Bloomberg
Powering Singapore’s genomic research with AWS and Illumina - AWS Blog
Metagenomics Market Report by Product, Technology, - GlobeNewswire
Metagenomics Market Report by Product, Technology, Application, and Region (2024-2032) Featuring Profiles of Agilent Technologies, Enterome, Eurofins Scientific, Roche, Illumina, Novogene, PerkinElmer & More - Yahoo Finance
Illumina's WGS as A Game-Changer for Rapid Blood Cancer Diagnostics - Yahoo Finance
Bioinformatics Market Outlook: Trends, Regulatory Changes, - openPR
Teachers Retirement System of The State of Kentucky Has $6.62 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Nomura Asset Management Co. Ltd. Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Public Employees Retirement System of Ohio Cuts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
National Bank of Canada FI Sells 211,120 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA and Gene Chip Market to See Huge Growth by 2030 | Greiner Bio-One, Illumina Inc., LC Sciences - openPR
The Growing Case for Whole-Genome Sequencing in All Blood Cancers - Illumina
Gene Panel Market 2024 Size, Global Report till 2031 | Illumina, Inc, Thermo Fisher Scientific, Agilent Technologies. - openPR
What Does Illumina, Inc.'s (NASDAQ:ILMN) Share Price Indicate? - Simply Wall St
Vestcor Inc Acquires 9,600 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Citigroup Downgrades Illumina (ILMN) - MSN
Illumina stock outlook cautious with headwinds from China and macro conditions - Investing.com
Illumina (NASDAQ:ILMN) Cut to Neutral at Citigroup - MarketBeat
DNA Sequencing Market: An Analysis of Size, Shares, Business - openPR
Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina - The Eastern Progress Online
European Court of Justice rules in favor of Illumina in jurisdictional appeal - The Eastern Progress Online
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Independent Testing Proves Dragen Provides a Vastly More Comprehensive Genome - Yahoo Finance
A landmark Japanese study reaches 100,000 genomes - Illumina
Genomic Cancer Testing Market CAGR of 16.7% Share, Opportunities and Growth Forecast 2024-2031 | Illumina, - EIN News
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):